Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TK2 | O00142 | 1/20 | 0.36 |
| ▸ | NT5M | Q9NPB1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3272988 | 1.00 | TK1 (0.41) | TK1HPGDTK2NT5M | |
| SCHEMBL3271976 | 0.95 | TK1 (0.42) | TK1HPGD | |
| SCHEMBL4554920 | 0.95 | TK1 (0.42) | TK1HPGD | |
| SCHEMBL20394019 | 0.86 | TK1 (0.41) | TK1HPGDTK2NT5M | |
| SCHEMBL13383034 | 0.85 | TK1 (0.40) | TK1HPGDTK2NT5M | |
| SCHEMBL23264572 | 0.84 | TK1 (0.41) | TK1HPGDTK2NT5M | |
| SCHEMBL20394066 | 0.84 | TK1 (0.43) | TK1HPGDTK2NT5M | |
| SCHEMBL26738687 | 0.84 | TK1 (0.41) | TK1HPGDTK2NT5M | |
| SCHEMBL23264576 | 0.84 | TK1 (0.41) | TK1HPGDTK2NT5M | |
| SCHEMBL16648604 | 0.84 | TK1 (0.41) | TK1HPGDTK2NT5M |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2134736-A1 | FIVE- AND SIX-MEMBERED CONFORMATIONALLY LOCKED 2',4'- CARBOCYCLIC RIBO-THYMIDINES FOR THE TREATMENT OF INFECTIONS AND CANCER | Chattopadhyaya, Jyoti (SE) | 2009-12-23 | — | — | EP | disclosed |
| WO-2008111908-A1 | FIVE- AND SIX-MEMBERED CONFORMATIONALLY LOCKED 2',4'- CARBOCYCLIC RIBO-THYMIDINES FOR THE TREATMENT OF INFECTIONS AND CANCER | CHATTOPADHYAYA JYOTI (SE) | 2008-09-18 | — | — | WO | disclosed |